J S Rogers Selected Research

Drug Therapy (Chemotherapy)

1/2001

A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J S Rogers Research Topics

Disease

1	Dandruff 07/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2001
1	Neoplasms (Cancer) 01/2001
1	Neoplasm Metastasis (Metastasis) 11/2000

Drug/Important Bio-Agent (IBA)

1	CeramidesIBA 07/2002
1	CholesterolIBA 07/2002
1	Environmental Pollutants (Pollutants, Environmental)IBA 07/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2002
1	LipidsIBA 07/2002
1	MycotoxinsIBA 07/2002
1	irofulvenIBA 01/2001
1	Antineoplastic Agents (Antineoplastics)IBA 01/2001

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2001
1	Thoracotomy 11/2000